A novel spherically shaped core@double-shell acidic nanocatalyst (FeO@SiO@RF-SOH) [RF: resorcinol-formaldehyde resin] was prepared and completely characterized using X-ray diffraction, Fourier transform infrared spectroscopy, vibrating sample magnetometry, energy dispersive X-ray spectroscopy, thermogravimetric analysis, transmission electron microscopy and field-emission scanning electron microscopy. The concentration of H loaded on the FeO@SiO@RF was reported to be 1.3 mmol g. The well-defined FeO@SiO@RF-SOH core-shell heterostructures exhibited high stability, efficient recyclability (10 cycles), and promoted catalytic activity for one-pot condensation reaction between the aromatic aldehydes, dimedone, malononitrile, and ammonium acetate for the synthesis of hexahydroquinoline derivatives.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057767 | PMC |
| http://dx.doi.org/10.1039/d0ra06972h | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and characterization of new hexahydroquinoline derivatives and evaluation of their cytotoxicity, intracellular ROS production, and inhibitory effects on inflammatory mediators.
Turk J Chem
July 2024
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.
Inflammation is a response to injury and infection in an organism. It can be categorized as acute or chronic. Chronic inflammation is the underlying cause of many diseases such as Alzheimer disease, diabetes, rheumatoid arthritis, atherosclerosis, and cardiovascular diseases.
View Article and Find Full Text PDFOptimization of diastereomeric dihydropyridines as antimalarials.
Eur J Med Chem
September 2024
Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL, 33620, United States; Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, United States; Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, United States. Electronic address:
The increase in research funding for the development of antimalarials since 2000 has led to a surge of new chemotypes with potent antimalarial activity. High-throughput screens have delivered several thousand new active compounds in several hundred series, including the 4,7-diphenyl-1,4,5,6,7,8-hexahydroquinolines, hereafter termed dihydropyridines (DHPs). We optimized the DHPs for antimalarial activity.
View Article and Find Full Text PDFSome pyrimidohexahydroquinoline candidates: synthesis, DFT, cytotoxic activity evaluation, molecular docking, and studies.
RSC Adv
May 2024
Chemistry Department, Faculty of Science, Ain Shams University Cairo 11566 Egypt
Some hexahydroquinoline candidates were prepared by reacting 2-amino-3-cyano-1-cyclohexylhexahydroquinoline with oxalyl chloride and triethyl orthoformate. The computational chemical approach agreed with the product-testing results. The produced substances were examined for their antiproliferative activity against liver carcinoma (HepG2), breast adenocarcinoma (MCF7), prostate cancer (PC3), and colon cancer (HCT116) cell lines.
View Article and Find Full Text PDFA Highly Efficient Strategy for One-Pot and Pseudo-Six-Component Synthesis of Hexahydroquinolines.
ACS Omega
January 2024
Molecular Design and Synthesis, Department of Chemistry, KU Leuven, Leuven 3000, Belgium.
In this study, a homogeneous acid-catalyzed reaction of a series of benzaldehydes, benzylamines, and Meldrum's acid was presented, allowing the novel one-pot and multicomponent synthesis of hexahydroquinolines with high stereoselectivity. The current strategy has advantages including high regioselectivity, good efficiency, reasonable diversity, utilization of an inexpensive and safe catalyst, and easy purification of products by simple recrystallization. The current reaction utilizes 2 equiv of Meldrum's acid, 3 equiv of benzaldehyde derivatives, and one equiv of amine derivatives to yield (4'S,5'S,7'S)-1'-benzyl-2,2-dimethyl-4',5',7'-triphenyl-3',4',7',8'-tetrahydro-1'-spiro[[1,3]dioxane-5,6'-quinoline]-2',4,6(5')-trione derivatives.
View Article and Find Full Text PDFFree fatty acid 3 receptor agonist AR420626 reduces allergic responses in asthma and eczema in mice.
Int Immunopharmacol
January 2024
Department of Biomedical and Pharmaceutical Sciences, Seoul 02446, Republic of Korea; Department of Fundamental Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea. Electronic address:
Free fatty acid 3 receptor (FFA3; previously GPR41) is a G protein-coupled receptor that senses short-chain fatty acids and dietary metabolites produced by the gut microbiota. FFA3 deficiency reportedly exacerbates inflammatory events in asthma. Herein, we aimed to determine the therapeutic potential of FFA3 agonists in treating inflammatory diseases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!